OKYO Pharma Announces Proposed Public Offering of Ordinary Shares LONDON and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...

DIGITAL ALLY ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK Lenexa, KS, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products and other critical safety...

Akers Biosciences Prices $6,000,000 Public Offering THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...